Nimspas DM 80mg/250mg Tablet
Marketer
Veewin Healthcare Pvt Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Nimspas DM 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, Nimspas DM 80mg/250mg Tablet. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing chemical signals. Nimspas DM 80mg/250mg Tablets should be taken with food, following your physician's prescribed dosage and duration. Your individual dose will be determined by your condition and response to treatment. Continue the medication as directed; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn. Most resolve spontaneously; however, report any concerns to your doctor immediately. Dizziness and drowsiness may occur; refrain from driving or mentally demanding activities until the effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Disclose pregnancy, pregnancy planning, breastfeeding, kidney, or liver disease to your doctor before starting this medication to ensure appropriate dosage.
Primary Ingredients of Nimspas DM 80mg/250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Nimspas DM 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Nimspas DM 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Nimspas DM 80mg/250mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
Common Side effects of Nimspas DM 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Nimspas DM 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Nimspas DM 80mg/250mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Nimspas DM 80mg/250mg Tablet works:
Each Nimspas DM 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of pain and inflammation-causing chemicals.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Nimspas DM 80mg/250mg tablets should not be taken together due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Nimspas DM 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Nimspas DM 80mg/250mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Nimspas DM 80mg/250mg Tablets, a potential side effect of this medication being vertigo.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Nimspas DM 80mg/250mg tablets, potentially requiring dosage modification. A physician's consultation is advised. The use of Nimspas DM 80mg/250mg tablets is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Nimspas DM 80mg/250mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Nimspas DM 80mg/250mg Tablet :
Should you forget a Nimspas DM 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nimspas DM 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently